Hims & Hers stock drops. It may be losing its weight-loss battle with Novo.

Shares in the Danish drugmaker have tanked this week, dragged down by a weak sales outlook and the launch of a Wegovy ...

Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option

Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an ...

Hims & Hers is introducing a cheaper Wegovy copycat. Novo Nordisk stock falls.

Hims & Hers’ new alternative to Novo Nordisk’s Wegovy pill will sell for $49 for the first month and $99 a month after that.

Hims & Hers Expands Personalized Weight Loss Portfolio with Access to Compounded Semaglutide Pills Starting at $49/Month*

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced an expansion ...
Devdiscourse

Hims & Hers' Disruptive Move with Compounded Weight-Loss Pills

Hims & Hers plans to launch a compounded version of Novo Nordisk's Wegovy pill at $49 a month. This move, echoing its ...
Daily Jang

Hims & Hers weight-loss pill sends shockwaves across pharma industry

Him & Hers’ announcement of a low-cost weight loss has jolted the pharmaceutical industry, but the company’s volatile stock failed to hold early gains.The Danish drug manufacturer revealed plans to ...
Nasdaq

Hims & Hers Expands Weight-Management Program to the United Kingdom

Hims & Hers HIMS recently announced that it is expanding access to its comprehensive Weight Loss Program to customers in the United Kingdom. The company is launching its Hers platform to provide ...
KEYT

Shopping for a 7-day weight loss meal plan at 5 grocery stores: Which is cheaper?

Planning home-cooked meals can help you reach your health and weight loss goals. In fact, research supports that eating at home more versus going out may help you naturally consume fewer daily ...